General Information of the Compound
| Compound ID |
CP0223924
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-([1,3]oxazolo[4,5-b]pyridin-2-yl)pentan-1-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(oxazolo[4,5-b]pyridin-2-yl)-1-oxo-pentane
1-(oxazolo[4,5-b]pyridin-2-yl)pentan-1-one
288862-78-2
BDBM50350542
CHEMBL402740
SCHEMBL3961770
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H12N2O2
|
||||||||||||||||||
| Molecular Weight |
204.229
|
||||||||||||||||||
| Canonical SMILES |
CCCCC(=O)c1nc2ncccc2o1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H12N2O2/c1-2-3-5-8(14)11-13-10-9(15-11)6-4-7-12-10/h4,6-7H,2-3,5H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
FBFLUTUPSIYUIG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( 1-(oxazolo[4,5-b]pyridin-2-yl)pentan-1-one )
| Drug Name | 1-(oxazolo[4,5-b]pyridin-2-yl)pentan-1-one | ||
|---|---|---|---|